Navigation Links
Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
Date:12/26/2007

erapeutics. The company is dedicated to becoming the leader in the field of RNAi technology by spearheading into the targeted therapeutics market. The company's partnership with big pharmas and major biotech companies, along with government funding and venture capital financing, will strengthen its financial resources to accelerate the development of the technology platforms and siRNA therapeutic products. The strong ties with biopharmaceutical communities in Asia (China) allow the company to speed up its pre-clinical and clinical processes for novel siRNA therapeutic development with low cost. The company's proprietary "Tri-Blocker" technology for multi-targeted siRNA cocktail design and "Snano" series of nanoparticle delivery systems enable its advanced RNAi therapeutic programs for treatment of various critical human conditions including aging diseases, infectious diseases and cancer. The leading product, STP601, a multi-targeted siRNA cocktail therapeutics for treatment of ocular neovascularization such as AMD, PDR and HSK, is expected to be in clinic in 2008, in addition to an enriched product pipeline of siRNA therapeutics. Since the summer of 2007, Sirnaomics has received a number of angel investments related to the State of Maryland Tax Credit Programs for Biotechnology Investment. The company has also received the TGP grant from Montgomery County and has recently been awarded a two-year MIPS grant jointly with Professor James Mixson of University of Maryland. In addition, the company has also received an investment from the State of Maryland DBED Challenge Investment Fund.

"The Governmental fundings play the critical role in Sirnaomics early stage financing," said the founder, President and CEO of the company, Dr. Patrick Y. Lu. "It not only supplies initial fuel for us to take off, but more importantly provides solid foundation for our staged financing strategy, to ensure the long term health of the company's financial structure." Dr. Lu further emp
'/>"/>

SOURCE Sirnaomics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
4. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
5. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
6. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
7. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device
10. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
11. New Report Analyzes Key Controversies in Multiple Sclerosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... throughput research solutions, today announced that Lupin Limited, one ... of Freeslate’s CM Protégé PharmD System for ... in Mumbai, India, is focused on a wide range ...
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... YORK, June 8, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0548785/Future-of-White-Biotechnology-in-China.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ... referred to the third wave in biotechnology, ...
... 7, 2011 Vaxart, Inc., a San Francisco biotechnology company ... I clinical trial. This is the first clinical study evaluating ... The trial site is in the United States. ... is demonstrated with one vaccine, we can expect that later ...
... 7, 2011 Infrared Systems International (OTCBB: IFRS) is pleased ... pilot study of its NatuRx™ HIV/AIDS treatment and will push ... AquaLiv concluded a pilot study with two HIV/AIDS patients ... of the first reported AIDS victims on June 5th, 1981. ...
Cached Biology Technology:Reportlinker Adds Future of White Biotechnology in China 2Reportlinker Adds Future of White Biotechnology in China 3Reportlinker Adds Future of White Biotechnology in China 4Reportlinker Adds Future of White Biotechnology in China 5Vaxart Begins First Oral Vaccine Clinical Trial 2Infrared Systems International's Subsidiary, AquaLiv, Inc., Strives to Be a Game Changer in Fight Against HIV/AIDS 2Infrared Systems International's Subsidiary, AquaLiv, Inc., Strives to Be a Game Changer in Fight Against HIV/AIDS 3
(Date:4/22/2014)... research projects study the effects of temperature and precipitation ... However, an important component of climate research, the UV-B ... in collaboration with their colleagues from the Universities in ... from the U.S. NASA space agency in such a ... influence of UV-B radiation on organisms. , The basic ...
(Date:4/22/2014)... another way of asking him or her to behave ... cells of the immune system tend to misbehave with ... these cells are known to misbehave similarly during spaceflight, ... cells to better understand how our immune systems change ... on Aging, part of the National Institutes of Health, ...
(Date:4/22/2014)... Recent projects in two Minnesota cities demonstrate how ... projects continue a ten year program in New ... plans tailored to local conditions. , "Our goal ... protect themselves," said program co-leader Latham Stack, of ... have already worsened. We help communities move beyond ...
Breaking Biology News(10 mins):UV-radiation data to help ecological research 2For an immune cell, microgravity mimics aging 2For an immune cell, microgravity mimics aging 3For an immune cell, microgravity mimics aging 4For an immune cell, microgravity mimics aging 5Minnesota projects offer hope and practical help to communities facing more extreme storms 2
... the journal Clinical Cancer Research, a journal ... non-invasive screening method with future potential for detection of ... In the study, researchers at Johns Hopkins University used ... identify oral HPV infections in patients with HPV16-positive and ...
... one in the United States and one in Australia, ... visualizing the invisible processes at work in several human ... the Optical Society,s (OSA) Interactive Science Publishing (ISP) initiative, ... large three-dimensional data and gives researchers, scientists and engineers ...
... 29, 2008 -- Vitamin E has been heralded for its ... and sudden death. Yet in some people, vitamin E causes ... excess vitamin E promotes bleeding by interfering with vitamin K, ... able to pinpoint how the two vitamins interact. Nutrition researcher ...
Cached Biology News:Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening 2OSA's ISP launches with research on breathing disorders and congenital heart defects 2OSA's ISP launches with research on breathing disorders and congenital heart defects 3OSA's ISP launches with research on breathing disorders and congenital heart defects 4
These 25x25 square No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 102...
... of Cell Cultures (ECACC) has been offering ... and government institutes for over seven years. ... to introduce candidates to cell culture and ... more specialist areas such as planning and ...
...
These 22x40mm rectangular No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 73...
Biology Products: